| Literature DB >> 8039289 |
P Goupille1, J L Poet, F Jattiot, J P Mattei, V Védère, I Tonolli-Serabian, H Roux, J P Valat.
Abstract
The authors report three cases of arthritis occurring after treatment with BCG immunotherapy for bladder disease. This complication is observed in 0.5 to 1% of treated patients and affects the small joints within 1 to 5 months of the first BCG injection. The clinical outcome is favourable with non-steroidal antiinflammatory drugs. This form of arthritis may be attributable to a cross-reaction between antigenic components of cartilaginous proteoglycan and BCG, influenced by a particular HLA-DR pattern, and with the intervention of a heat shock protein.Entities:
Mesh：
Substances：
Year: 1994 PMID： 8039289
Source DB: PubMed Journal: Clin Exp Rheumatol ISSN： 0392-856X Impact factor: 4.473